In 2014 the company ventured into generic pharmaceutical development. By 2015 a total of 15 products have been registered and a vast pipeline of new products are under registration with various regulatory authorities in Southern Africa. We project Cospharm to be the fastest growing pharmaceutical company in the next 5 years. With its wide range of Acute antibiotic medicines, Cardiovascular (CVS) medicines, Female Hormone medicines and Impressive NSAID/ Analgesic range, Cospharm expects to be a key market player in the region. The growth success of the company is attributed in part to highly qualified personnel with a clear pharmaceutical market understanding and in part to its practice of partnering with best manufacturers globally. In this respect Cospharm differs from other generic pharmaceutical companies, who rely on internal expertise and development.

With its wide range of Acute antibiotic medicines, Cardiovascular (CVS) medicines, Female Hormone medicines and Impressive NSAID/ Analgesic range, Cospharm expects to be a key market player in the region.

The growth success of the company is attributed in part to highly qualified personnel with a clear pharmaceutical market understanding and in part to its practice of partnering with best manufacturers globally. In this respect Cospharm differs from other generic pharmaceutical companies, who rely on internal expertise and development.